{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:57:42Z","timestamp":1776103062255,"version":"3.50.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare inherited arrhythmia disorder characterized by ventricular arrhythmia triggered by adrenergic stimulation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 9-year-old boy presented with convulsions following physical exertion. Bidirectional ventricular tachycardia (VT) during a treadmill test led to the diagnosis of catecholaminergic polymorphic ventricular tachycardia (CPVT). Genetic testing revealed a pathogenic variant of <jats:italic>RYR2:c.720G&amp;gt;A (p.ArG2401His)<\/jats:italic>. Nadolol was initially started. However, he experienced aborted VT arrest three years later. Flecainide was thus added as dual therapy and he underwent left cardiac sympathetic denervation (LCSD). Subsequently, a transvenous implantable cardioverter-defibrillator (ICD) was implanted because he still had several episodes of bidirectional VT. Despite a good compliance to medication, the patient still had exercise induced VT episodes with new onset of atrial fibrillation. High dose nadolol was required and amiodarone was added. Despite maximizing the dosage of these three antiarrhythmics, the patient continued to experience multiple episodes of ventricular fibrillation with appropriate ICD shocks and persistent atrial arrhythmias. Right cardiac sympathetic denervation (RCSD) was performed as the last modality of treatment. Patient had a total elimination of VT post bilateral sympathectomy. He remained asymptomatic on follow up. A follow-up treadmill test showed no recurrence of exercise-induced PVCs and VT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We illustrated the challenges and the complex decision-making process encountered in managing refractory CPVT. In patients unresponsive to conventional therapies, RCSD in additional to LCSD is a safe and effective alternative treatment. A history of LCSD should not preclude physicians from considering RCSD in children with refractory CPVT.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2024.1477359","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T06:22:27Z","timestamp":1734070947000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: The unrelenting journey\u2014successful resolution of catecholaminergic polymorphic ventricular tachycardia (CPVT) through right cardiac sympathetic denervation in a teenager after left cardiac sympathetic denervation"],"prefix":"10.3389","volume":"11","author":[{"given":"Hei-To","family":"Leung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sit-Yee","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucius Kwok-Fai","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.121.056018","article-title":"An international multicenter cohort study on \u03b2-blockers for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia","volume":"145","author":"Peltenburg","year":"2022","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12872-020-01843-0","article-title":"Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre","volume":"21","author":"Capponi","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.123.064786","article-title":"Flecainide is associated with a lower incidence of arrhythmic events in a large cohort of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"148","author":"Bergeman","year":"2023","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1161\/CIRCRESAHA.116.305347","article-title":"The mechanism of flecainide action in CPVT does not involve a direct effect on RyR2","volume":"116","author":"Bannister","year":"2015","journal-title":"Circ Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1001\/jamacardio.2022.0219","article-title":"Outcomes of patients with catecholaminergic polymorphic ventricular tachycardia treated with \u03b2-blockers","volume":"7","author":"Mazzanti","year":"2022","journal-title":"JAMA Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/CIRCEP.113.000170","article-title":"Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate","volume":"6","author":"Miyake","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.hrthm.2010.03.046","article-title":"Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy","volume":"7","author":"Odero","year":"2010","journal-title":"Heart Rhythm"},{"key":"B9","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1056\/NEJM197110142851607","article-title":"Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome","volume":"285","author":"Moss","year":"1971","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3389\/fphys.2018.01281","article-title":"The role of neuropeptide Y in cardiovascular health and disease","volume":"9","author":"Tan","year":"2018","journal-title":"Front Physiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fcvm.2019.00027","article-title":"Cardiac sympathetic denervation in channelopathies","volume":"6","author":"Dusi","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1093\/eurheartj\/ehz950","article-title":"There are 100 ways by which the sympathetic nervous system can trigger life-threatening arrhythmias","volume":"41","author":"Dusi","year":"2020","journal-title":"Eur Heart J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1161\/CIRCULATIONAHA.115.015731","article-title":"Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation","volume":"131","author":"De Ferrari","year":"2015","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jtcvs.2013.07.064","article-title":"Left thoracoscopic sympathectomy for cardiac denervation in patients with life-threatening ventricular arrhythmias","volume":"147","author":"Hofferberth","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1161\/CIR.0000000000000549","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the heart rhythm society","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1586\/erc.12.93","article-title":"Bilateral cardiac sympathetic denervation: why, who and when?","volume":"10","author":"Ajijola","year":"2012","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"B17","doi-asserted-by":"publisher","first-page":"13311","DOI":"10.3390\/ijms232113311","article-title":"Stellate ganglia and cardiac sympathetic overactivation in heart failure","volume":"23","author":"Li","year":"2022","journal-title":"IJMS"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1113\/JP271870","article-title":"Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics","volume":"594","author":"Shivkumar","year":"2016","journal-title":"J Physiol (Lond)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.hrthm.2013.11.028","article-title":"Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up","volume":"11","author":"Vaseghi","year":"2014","journal-title":"Heart Rhythm"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.hrthm.2008.07.007","article-title":"Successful treatment of catecholaminergic polymorphic ventricular tachycardia with bilateral thoracoscopic sympathectomy","volume":"5","author":"Scott","year":"2008","journal-title":"Heart Rhythm"},{"key":"B21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.joa.2015.07.002","article-title":"Efficacy of bilateral thoracoscopic sympathectomy in a patient with catecholaminergic polymorphic ventricular tachycardia","volume":"32","author":"Okajima","year":"2016","journal-title":"J Arrhythm"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1111\/jocs.15652","article-title":"Bilateral thoracoscopic sympathectomy for cardiac denervation in pediatric population: does kuntz nerve cauterization have an impact on success?","volume":"36","author":"Ertugrul","year":"2021","journal-title":"J Card Surg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.hrthm.2019.12.007","article-title":"Prognostic impact of atrial rhythm and dimension in patients with structural heart disease undergoing cardiac sympathetic denervation for ventricular arrhythmias","volume":"17","author":"Dusi","year":"2020","journal-title":"Heart Rhythm"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1477359\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T06:22:29Z","timestamp":1734070949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1477359\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":23,"alternative-id":["10.3389\/fcvm.2024.1477359"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1477359","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]},"article-number":"1477359"}}